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Abstract
Objectives
To obtain compensatory ultra-short echo time (UTE) imaging and T2-weighted (T2W) imag-
ing of Watanabe heritable hyperlipidemic (WHHL) rabbits following dextran-coated magnet-
ic nanocluster (DMNC) injection for the effective in vivo detection of inflammatory vascular
wall.
Methods
Magnetic nanoparticle was synthesized by thermal decomposition and encapsulated with dex-
tran to prepare DMNC. The contrast enhancement efficiency of DMNCwas investigated using
UTE (repetition time [TR] = 5.58 and TE = 0.07 ms) and T2W (TR = 4000 and TE = 60ms) im-
aging sequences. To confirm the internalization of DMNC into macrophages, DMNC-treated
macrophages were visualized by cellular transmission electron microscope (TEM) andmag-
netic resonance (MR) imaging. WHHL rabbits expressing macrophage-rich plaques were sub-
jected to UTE and T2W imaging before and after intravenous DMNC (120 μmol Fe/kg)
treatment. Ex vivoMR imaging of plaques and immunostaining studies were also performed.
Results
Positive and negative contrast enhancement of DMNC solutions with increasing Fe concen-
trations were observed in UTE and T2W imaging, respectively. The relative signal intensi-
ties of the DMNC solution containing 2.9 mM Fe were calculated as 3.53 and 0.99 in UTE
and T2W imaging, respectively. DMNC uptake into the macrophage cytoplasm was visual-
ized by electron microscopy. Cellular MR imaging of DMNC-treated macrophages revealed
relative signals of 3.00 in UTE imaging and 0.98 in T2W imaging. In vivoMR images re-
vealed significant brightening and darkening of plaque areas in the WHHL rabbit 24 h after
DMNC injection in UTE and T2W imaging, respectively. Ex vivoMR imaging results agreed
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with these in vivoMR imaging results. Histological analysis showed that DMNCs were local-
ized to areas of inflammatory vascular wall.
Conclusions
Using compensatory UTE and T2W imaging in conjunction with DMNC is an effective ap-
proach for the noninvasive in vivo imaging of atherosclerotic plaque.
Introduction
Superparamagnetic nanoparticles have been widely applied as MR imaging contrast agents and
molecular imaging probes combined with a targeting moiety in clinical studies, as in magnetic
cell tracking with MR imaging, molecular imaging via MR imaging, and MR imaging-guided
theragnosis.[1–6] In most cases, magnetic nanoparticles have been used as T2 shortening nega-
tive contrast agents in T2W imaging, but have rarely been used for T1 contrast enhancement
because of the predominant spin diphase effect of magnetic nanoparticles.[7–9] A fundamental
drawback of T2W imaging with negative contrast, however, is that the agent cannot be distin-
guished from other sources of signal loss in the image due to intrinsic signal voids, such as mo-
tion artifacts, hemorrhage, and organs with originally low background signals, such as lung
(air) and lumen (blood). Additionally, accumulation of magnetic nanoparticles induces strong
dephasing with image distortion, making accurate localization and quantitative imaging diffi-
cult.[10, 11]
UTE imaging, which involves positive contrast based on extremely short echo time, allowing
for T1 signal acquisition with suppressed T2 decay from magnetic nanoparticles, can supple-
ment the limitations of negative contrast imaging.[12, 13] In this study, we developed a dex-
tran-coated magnetic nanocluster (DMNC) as a molecular imaging probe to enable the precise
detection of macrophages expressing scavenger receptor A (SR-A) via compensatory UTE and
T2W imaging. SR-A family is expressed on the cell surface of tissue macrophages, including
macrophage foam cells, and have been detected on aortic endothelial cells and vascular smooth
muscle cells within atherosclerotic plaque, thus SR-A are currently one of the most appealing
targets at all stages of atherosclerosis.[14] In previous research, dextran and their derivatives
(sulfated dextran, carboxyl dextran, and thiol-dextran) could be used for targeting SR-A, thus
dextran layer on the surface of DMNC was designed for preferential uptake into the cytoplasm
of macrophages through SR-A with highly biocompatible characteristics.[15–23] The magnetic
nanoparticle cluster core of the DMNC was introduced as both a positive and negative contrast
agent for UTE and T2W imaging. To assess the compensatory UTE and T2W imaging poten-
tial of DMNC, solution MR imaging and cellular MR imaging experiments were performed
and in vivoMR imaging was conducted in WHHL rabbits as a chronic inflammation model
with macrophage-initiated atherosclerotic plaques, following the intravenous injection of
DMNC.[24–26] In atherosclerosis, macrophage accumulation leads to the formation of unsta-
ble plaques by inducing the production of various cytokines and chemokines, and may result
in sudden death due to the rupture of the thrombus.[27–29] Compensatory UTE and T2W im-
aging of macrophages based on DMNC should overcome the limitations of a single negative
contrast imaging sequence, provide accurate diagnoses, and facilitate the pathological investi-
gation of atherosclerosis.
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Methods
Dextran-coated Magnetic Nanocluster (DMNC)
For the synthesis of DMNC, the details of the compound are descibed here. Dextran T-10
(Mw: 10,000 Da) was obtained from Pharmacia Biotech. 1-Pyrenebutyric acid, 1,3-dicyclohex-
ylcarbodiimide, 4-dimethylaminopyridine, anhydrous dimethyl sulfoxide, triethylamine, iron
(III) acetylacetonate, 1,2-hexadecanediol, oleic acid, oleylamine, and benzyl ether were pur-
chased from Sigma-Aldrich. Centrifugal filters (Amicon Ultra, 30,000 MWCO cut-off) were
purchased fromMillipore. Hydrophilic syringe filters with 0.45 μm pore size (DISMIC, PTFE
25HP045AN) were purchased from ADVANTEC. All other chemicals and reagents were of an-
alytical grade and obtained from Sigma-Aldrich.
DMNC was synthesized as described in our previous studies. We synthesized monodisperse
12-nm magnetic nanoparticle (MNP) by seed-mediated growth through the thermal-decom-
position method. Pyrenyl dextran (Pydex), amphiphilic polymer was synthesized for the im-
mobilization of the hydrophobic surface of MNP. To synthesize Pydex, the hydroxyl group of
dextran was conjugated with the carboxylic acid of 1-pyrenebutyric acid through the esterifica-
tion reaction. To prepare DMNC, MNP was then clustered and coated with Pydex through the
nanoemulsion method.
The size and morphology of DMNC were investigated using transmission electron micros-
copy (TEM, JEM-2100 LAB6, JEOL Ltd.). The hydrodynamic diameter and surface charge of
DMNC were measured using laser scattering (ELS-Z, Otsuka Electronics). The magnetic hys-
teresis loop and the saturation magnetization of DMNC were determined in dried samples at
room temperature using a vibrating sample magnetometer (Model-7300, Lakeshore).
Solution MR Imaging of DMNC
Solution MR imaging experiments were performed using a SIEMENS 3.0 T MR imaging sys-
tem (MAGNETOM Trio, SIEMENS) with an 8-channel wrist coil using the UTE and T2W im-
aging sequences. The sequence parameters for UTE imaging were TR = 5.58 ms, TE = 0.07 ms,
flip angle = 20°, field of view: 200 × 100 mm2, voxel size = 0.5 × 0.5 × 1 mm3, and number of ac-
quisitions = 1, and the sequence parameters for T2W imaging were TR = 4,000 ms, TE = 60
ms, flip angle = 20°, field of view: 200 × 100 mm2, voxel size = 0.5 × 0.5 × 1 mm3, and number
of acquisitions = 1. Tubes containing the DMNC solution with various Fe concentrations were
mounted in a sample holder and located at the iso-center of the magnet for MR imaging.
To measure the DMNC signal intensity, circular regions of interest (ROI) were placed on in-
dividual images of each solution sample. After measuring the signal intensities of each sample
and water, the relative signal intensity was calculated as follows: │I—Iwater│/Iwater where I and
Iwater are the signal intensities of the selected DMNC sample and water, respectively. The rela-
tive signal intensity was then plotted versus Fe concentration.
In vitro experiments
RAW264.7 cells (8.0 × 108 cells) were implanted in a Petri dish at 37°C overnight and washed
three times using phosphate-buffered saline (PBS, pH 7.4). The cells were then treated with
DMNC (20 μg Fe) for 24 h. Subsequently, the cells were washed with PBS three times to elimi-
nate unbound DMNC, detached using a cell scraper, and collected and re-suspended in 200 μL
of fixation solution.[30–32] Cellular internalization was verified by MR imaging and transmis-
sion electron microscopy (TEM, JEOL-1100). In vitroMR imaging experiments followed the
same procedure as that used for MR imaging of the DMNC solution.
UTE/T2W Imaging of Inflammatory Vascular Wall
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Animal preparation
WHHL rabbits were supported by the Cardiovascular Product Evaluation Center (CPEC) in
the Yonsei University Health System, Korea (www.cpec.co). Experiments were conducted in
10-month-old male WHHL rabbits with body weights of 3.0±0.4 kg. At this age, Watanabe rab-
bits exhibit active plaque formation within their aortic walls.[24, 26] Ten-month-old male New
Zealand White rabbits with, body weights of 2.8±0.5 kg were purchased from DooYeol Biotech,
Korea (www.dybiotech.co.kr) and used as normal controls. All rabbits survived until subse-
quent sacrifice without any clinical signs of respiratory or cardiac failure during the study. All
animal experiments were conducted with the approval of the Institutional Animal Care and
Use Committee Yonsei University Health System (Project No. 2011–0094).
Animal MR imaging experiment
In vivoMR imaging experiments were performed with a SIEMENS 3.0 T MR imaging system
(MAGNETOM Trio, SIEMENS) with an 8-channel knee coil using the UTE and T2W imaging
sequences. In vivoMR imaging of the rabbit aorta was performed before and after the adminis-
tration of DMNC into the rabbit ear vein using a syringe (120 μmol Fe/kg). Specifically, ani-
mals were imaged prior to DMNC injection (0 h), and then imaging was repeated at 0.25 h
(immediate), 2 h on day 0, and 24 h on day 1 following DMNC injection. After in vivoMR
imaging, the rabbit was subsequently sacrificed with an overdose of thiopental, and the
rabbit aorta was extracted immediately. Subsequently, ex vivoMR imaging of aortic wall
was performed. Animal UTE images were obtained using the following sequence parameters:
TR = 5.58 ms, TE = 0.07 ms, flip angle = 20°, field of view: 200 × 100 mm2, voxel size =
0.5 × 0.5 × 1 mm3, and number of acquisitions = 1. For animal T2W imaging, the following se-
quence parameters were adopted: TR = 4,000 ms, TE = 60 ms, flip angle = 20°, field of view:
200 × 100 mm2, voxel size = 0.5 × 0.5 × 1 mm3, and number of acquisitions = 1. Fifty transverse
(thoracic aorta) and 50 (aortic arch) slices were acquired from both sequences.
Data analysis of MR imaging
All the animal MR imaging data were transferred from the MR imaging scanner to a Dicom
image server for quantitative analysis, and then the aortic wall area and the average signal in-
tensity were analyzed by Centricity IT software solutions (GE Healthcare). For the quantifica-
tion of intravascular contrast changes following DMNC injection, the signal intensity in the
lumen was calculated and plotted versus time.[26, 33]
Intravascular MR signal change after DMNC injection: For the quantification of signal in-
tensity in the lumen, regions of interest (ROI) were placed manually in the lumen of the aortic
arch and thoracic aorta. The signal intensity in the lumen was then plotted at various time in-
tervals after DMNC injection.
Contrast enhancement of the atherosclerotic plaque: Images were viewed with magnifica-
tion and pre- and post-DMNC injection images from any individual were adjusted to ensure
identical window/level settings. To allow exact matching between pre- and post-DMNC injec-
tion images, anatomical landmarks (position of the aortic arch, renal arteries, and iliac bifurca-
tion) were used to guide ROI positioning. The presence of DMNC within the plaque was
confirmed by noting whether the matched post-injection image contained a new region(s) of
low (for T2W images)/high (for UTE images) signal intensity within the vessel wall. On the
pre-DMNC injection image, the ring-shaped ROI was defined to include whole region of vessel
and vessel wall except lumen. The delineated ROI was then copied and transposed to the same
location on the post-DMNC injection image to provide a “mirror” location for comparative
analysis. The signal intensity of these ROI was then converted to color coded image.
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Statistical analysis: Statistical evaluation of data was performed using the analysis of vari-
ance test and Student’s t-test. A p-value less than 0.01 was considered statistically significant.
Histological analysis
For the histological analysis, the entire aorta from the aortic root to below the iliac bifurcation
was harvested. The aorta was stained with: 1) Oil Red O (ORO) for specific lipid staining; 2)
Hematoxylin and eosin (H&E) with Prussian blue (PB) staining for iron staining.
ORO staining: 30 mL ORO stock solution (0.5 g/100 mL isopropanol) was mixed with 20
mL distilled water to prepare the ORO working solution. Extracted rabbit aorta was rinsed
with 60% isopropanol and incubated with ORO working solution. After 15 min, the aorta was
rinsed with 60% isopropanol and distilled water to remove unabsorbed ORO.
H&E with PB staining: Specimens were dehydrated using ethanol and cleared with xylene.
Slices were mounted onto glass slides and soaked twice in a container filled with hematoxylin
for 10 min to stain nuclei, followed by rinsing with deionized water. The cytoplasm was count-
er-stained with eosin and dehydrated in the same manner as mentioned earlier. Subsequently,
the specimens were immersed in iron staining solution (20% hydrochloric acid: potassium fer-
rocyanate = 1:1) for 30 min at room temperature to stain iron content in tissues. Then the sam-
ples were rinsed in deionized water three times to remove residual staining solution.
All stained aorta from DMNC-treated WHHL rabbits (Experiment) were visualized using a
virtual microscope (Olympus BX51, Japan) and Olyvia software.[14, 34]
Results
UTE and T2W imaging of DMNC solution
To obtain compensatory UTE and T2W imaging, DMNC as a molecular imaging probe was
prepared and showed uniform and spherical shape with highly water-stability for 15 day (S1
Fig). To investigate the compensatory contrast enhancement effect, DMNC solutions contain-
ing various Fe concentrations were visualized by UTE and T2W imaging (Fig 1A). Positive
contrast enhancement was obtained in all DMNC samples using the UTE sequence. Recogniz-
able brightening without a contrast void occurred, followed by an increase in Fe concentrations
in all selected concentration ranges. In T2W imaging, a negative contrast effect was observed
in the DMNC solution. The solution samples were visibly darker until the Fe concentration
reached 0.18 mM. However, the contrast void was observed at Fe concentrations of 0.36 mM
and greater. The signal intensities of the DMNC solutions in UTE and T2W images are provid-
ed in S1 Table and agreed with the imaging results.
To quantify the contrast enhancement effect of DMNC, the relative signal intensity (arbi-
trary unit, a.u.) was calculated from each DMNC solution using the water signal intensity as
the baseline reference, and then plotted versus Fe concentration (Fig 1B).[26] At Fe concentra-
tions ranging from 0 to 0.18 mM, a significant increase in the relative signal intensity was ob-
served in T2W images (0 to 0.94) compared with UTE images (0 to 0.57). At Fe concentrations
over 0.18 mM, the relative signal intensity of DMNC in UTE images increased continuously
without signal saturation until the highest concentration used (3.53 at 2.92 mM). However, no
further increase in the saturated signal was observed in T2W images (0.99 at 2.92 mM) due to
signal voids.[12]
In vitro treatment of macrophages with DMNC
As shown in Fig 2, DMNC-treated macrophages (RAW264.7 cells) were visualized by cellular
TEM and MR imaging to confirm the uptake of DMNC into macrophages and to demonstrate
UTE/T2W Imaging of Inflammatory Vascular Wall
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the cellular MR imaging ability of DMNC.[16] As seen in cellular TEM images (Fig 2A), a con-
siderable amount of DMNCs (red arrow) were located in the cytoplasm of macrophages, and
the cellular structures were sustained without damage. In MR imaging of macrophages treated
with DMNC, UTE images exhibited positive contrast enhancement and T2W images showed
negative contrast enhancement, compared to non-treated cells (Fig 2B). To precisely quantify
the contrast enhancement effect of DMNC, the relative signal intensity was calculated and is
presented in Fig 2C. In UTE imaging, the relative signal intensity of macrophages treated with
DMNC showed a significant signal increase (3.00) compared with non-treated cells (1.07). On
the other hand, in T2W imaging, only a slight increase in the relative signal intensity was ob-
served in DMNC-treated cells (0.98) compared with non-treated cells (0.54), because of the
contrast void.
Characterization of atherosclerotic plaques
To demonstrate the in vivoMR imaging ability of DMNC based on compensatory UTE and
T2W imaging, the WHHL rabbit was chosen as a macrophage-induced atherosclerosis model
that shows plaque formation in its vessel wall.[24] To confirm the presence of atherosclerotic
lesions, ORO immunostaining was performed in WHHL and normal rabbits. WHHL rabbits
Fig 1. Solution MR imaging of DMNC. (a) UTE and T2W images of DMNC solution, and (b) relative signal intensity versus Fe concentration.
doi:10.1371/journal.pone.0124572.g001
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exhibited lipid-rich plaque formation with a completely red-stained aortic wall (Fig 3A), in
contrast to normal rabbits (Fig 3B) Wall thickening was observable in the WHHL rabbit (Fig
3C) from representative baseline T2W images of the aortic arch and the thoracic aorta, in con-
trast to normal rabbits (Fig 3D). The quantified wall thickness was 0.81±0.18 mm in the
WHHL rabbit and 0.46±0.13 mm in the normal rabbit (p<0.001, Fig 3E).[26]
Intraluminal MR imaging of WHHL rabbit after DMNC injection
As shown in Fig 4, compensatory UTE and T2W imaging of the aortic arch and thoracic
aorta were performed after intravenous injection of DMNC, and the signal intensity in the
lumen was calculated to investigate the intraluminal kinetics of DMNC inWHHL rabbits (▲,
UTE_aortic arch;4, UTE_thoracic aorta; ●, T2W_aortic arch; , T2W_thoracic aorta).[35] In
Fig 4A, UTE images of the lumen appeared characteristically dark (0 h) prior to treatment with
DMNC. Following DMNC injection, the lumen images brightened, reflecting the contribution
of DMNC to strong intravascular signal enhancement in the blood pool (0.25 h). Brightening
remained at 2 h and recovered by 24 h, because DMNC was removed from blood pool over
time due to excretion. However, no remarkable contrast change was found in T2W imaging re-
sults of the aorta, because the darkening effect of DMNC in T2W imaging was not distinctive
in the lumen, the background image of which is originally dark (Fig 4B).
Fig 2. In vitro treatment of macrophages with DMNC. (a) TEM image of macrophage treated with DMNC (inset: magnified image of selected area). (b)
UTE and T2W images and (c) relative signal intensities of macrophages following DMNC treatment (20 μg Fe).
doi:10.1371/journal.pone.0124572.g002
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Further, the signal intensity was measured in the intraluminal region and agreed with the
MR imaging results. The signal intensity obtained from UTE images showed that the signal in-
tensity significantly increased immediately following DMNC injection (▲: 91.3±7.7 to 291.6
±23.6,4: 92.1±4.7 to 272.6±3.3), and decreased at 2 h (▲: 201.4±3.0,4: 195.4±9.5), reverting
to baseline values by 24 h (▲: 90.5±10.2,4: 77.2±2.4) (Fig 4C). In the case of T2W imaging,
however, only a slight signal change was observed in the lumen (●: 41.0±4.9 and : 35.1±2.5 at
0 h, ●: 51.9±7.5 and : 35.3±1.6 at 0.25 h, ●: 40.6±5.1 and : 29.5±2.5 at 2 h, ●: 45.3±11.8 and :
36.1±2.6 at 24 h) (Fig 4D).
In vivoMR imaging of WHHL rabbit aorta after DMNC injection
To demonstrate the in vivoMR imaging ability of DMNC, the thoracic aorta in the WHHL
rabbit was visualized by compensatory UTE and T2W imaging after intravenous injection of
DMNC, as shown in Fig 5. On UTE imaging (Fig 5A), the vessel wall was homogeneously sup-
pressed, appearing a characteristic gray prior to DMNC injection (pre, upper row), while a
striking brightening (positive contrast) was seen following DMNC injection (red arrows in
post, upper row) because of DMNC deposition in the vessel wall. Upon T2W imaging (Fig 5B),
subtle spots of distortion (negative contrast) were detected in the aorta after DMNC injection
(red arrows in post, upper row) compared with baseline images (pre, upper row). Color-coded
images of the vessel wall indicate that overall signal increase appeared in the whole vessel wall
as seen that dark blue-purple are changed to red-green in UTE images (bottom row, Fig 5A).
In T2W images, some spots of region which is located on the border between vessel wall and
lumen are changed to red (bottom row, Fig 5B).
Fig 3. Characterization of atherosclerotic plaques.ORO staining of aorta of (a) WHHL rabbits and (b) normal rabbits. The aortic arch and thoracic aorta of
(c) WHHL rabbit and (d) normal rabbit were visualized by T2W imaging. (e) The vessel wall thickness of WHHL and normal rabbits were measured from the
MR imaging results (*p<0.0001).
doi:10.1371/journal.pone.0124572.g003
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Histological investigation of WHHL rabbit aorta
Ex vivoMR imaging and histological analysis of the extracted WHHL rabbit aorta was per-
formed to confirm the delivery of DMNC (Fig 6). In Fig 6A, ex vivoMR imaging of the ex-
tracted WHHL rabbit aorta treated with DMNC showed strong contrast enhancement in the
vessel wall in UTE and T2W images. Fig 6B shows an H&E stained aorta revealing the basic
morphology of the plaque lesion with a lipid core and macrophages deposition. The blue dots
within the plaque lesion, detected by PB staining (red arrow), indicate the presence of iron
from the DMNC.
Discussion
Advantageous features of compensatory UTE/T2W imaging based on
DMNC
The advance in this study is that DMNC for MR imaging of atherosclerotic plaque was initially
designed to optimize the structure and properties from nano-scale for sensitive detection of
atherosclerotic plaque. 1) Thermal-decomposition method to synthesize MNP improved con-
trast effect of MNP based on highly crystalline nano-structure.[2, 36] 2) Artificially fabricated
Pydex copolymer could provide macrophage-targetable moiety with suitable amphiphilic coat-
ing agent for hydrophobic MNP. 3) Nanoemulsion of MNP with Pydex fabricated dextran-
coated magnetic core consisted of clustered MNP which exhibited better contrast enhancement
effect than single MNP at same concentration.[37]
To supplement the typical drawback of T2W imaging, UTE imaging, which could enhance
the T1 effect of the magnetic nanoparticles, was suggested as a positive contrast imaging
Fig 4. Intravascular MR imaging of WHHL rabbit after DMNC injection. Aortic arch (red) and thoracic aorta (green) at 0, 0.25, 2, and 25 h after DMNC
injection (0 h: baseline without DMNC injection) were visualized by (a) UTE and (b) T2W imaging. The intravascular signal intensity of (c) UTE and (d) T2W
imaging was quantified and plotted versus time.
doi:10.1371/journal.pone.0124572.g004
Fig 5. In vivoMR imaging of WHHL rabbit aorta after DMNC injection. The thoracic aorta of theWHHL rabbit was visualized by (a) UTE and (b) T2W
imaging after DMNC treatment, and their color-coded images are presented (bottom row). Red arrows indicates contrast-enhanced regions.
doi:10.1371/journal.pone.0124572.g005
UTE/T2W Imaging of Inflammatory Vascular Wall
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technique. To capture the T1 enhancement effect from the magnetic nanoparticle, UTE imaging
uses rapid transmit/receive switching, radial mapping of k-space, and a very short non-selective
RF excitation of 60 μs that allows signal acquisition to start almost immediately after RF excita-
tion.[12] With respect to the solution MR imaging of DMNC (Fig 1), UTE images showed the
advantages of continuous brightening with positive contrast on a dark background without a
contrast void. However, the T2W imaging result represents the limitation of the contrast void
with indistinguishable images on a dark background. Although the relative signal intensity of
the UTE image (3.53) was 3.6 times higher than the relative signal intensity of the T2W image
(0.99) at the maximum Fe concentration (2.92 mM) of the DMNC solution, the relative signal
intensity at 0.18 mM Fe increased more sensitively, from 0 to 0.94, using T2W imaging as com-
pared to UTE imaging, which showed a change from 0 to 0.57. From the comparison of the
UTE and T2 imaging results of DMNC solution, we conclude that T2W shows sensitive contrast
Fig 6. Extracted rabbit aorta was investigated by MR imaging and histological staining. (a) Extracted
aorta was visualized by UTE and T2W imaging. (b) Histological investigation was performed by H&E, PB
staining. The rectangle in (a) the ex vivoMR Imaging indicates the area shown in (b).
doi:10.1371/journal.pone.0124572.g006
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and signal changes at low Fe concentrations, but that UTE imaging is the alternative solution
for contrast void and signal saturation of T2W imaging at high Fe concentrations.
Cellular imaging ability of DMNC via UTE/T2W imaging
Macrophages influence the clinical outcomes of various inflammatory diseases, including ath-
erosclerosis. Therefore, macrophage detection should help identify patients with subclinical
inflamed lesions, and provide new and important insights for preventive cardiovascular medi-
cine.[29]
The presented cellular TEM image in Fig 2A shows that macrophages internalize DMNC to
a large extent without damaging cellular structures. The underlying mechanisms of nanoparti-
cle uptake by macrophages remain incompletely understood, but a recent study has suggested
an interaction between macrophage SR-A and dextran.[38] To prove the biomedical utility of
compensatory UTE/T2W imaging using DMNC, cellular MR imaging of macrophages treated
with DMNC was performed (Fig 2B). UTE imaging of DMNC-laden macrophages exhibited
remarkably brightened contrast enhancement, whereas T2W imaging showed darkening with
a contrast void. Additionally, the relative signal of the UTE image (3.00) was 3.1 times higher
than that of the T2W image (0.98). These cellular MR imaging results indicate that UTE imag-
ing combined with DMNC is highly acceptable for sensitive macrophage detection, and can be
used in various in vitroMR imaging studies.
In vivo detection of macrophages with compensatory UTE/T2W imaging
using DMNC
To investigate the in vivomacrophage detection ability of DMNC via compensatory UTE/
T2W imaging, the WHHL rabbit, which develops macrophage-rich atherosclerotic plaques,
was chosen as the model of chronic inflammation. WHHL rabbits exhibit increased wall thick-
ness compared to normal rabbits, and show pronounced intimal thickening (0.35 mm thicker
than normal rabbit), associated with lipid- and macrophage-rich plaque formation (Fig 3).[24,
26, 28]
Before the detection of atherosclerotic plaques, the intraluminal kinetics of DMNC was ana-
lyzed based on intravascular contrast and signal change (Fig 4). Based on quantitative analysis
of the intraluminal signal, we observed that the signal intensity of blood at 24 h on day 1 ap-
proached the signal intensity of blood at baseline (0 h), which indicated complete clearance of
the agent from the blood pool at this point. The clearance of DMNC in the blood pool provided
better contrast between the lumen and DMNC-deposited macrophages on the aortic wall.
Therefore, the optimal time for effective analysis of in vivo aortic wall MR images was 24 h
after DMNC administration. Furthermore, UTE imaging was found to be a better technique
than T2W imaging for studying intraluminal DMNC kinetics, because UTE imaging provides
a sensitive signal change (200.3 = 291.6–91.3) with an accurately distinguishable intraluminal
contrast change, whereas T2W imaging shows a slight signal change (10.9 = 51.9–41.0) with no
remarkable intraluminal contrast change.
Using DMNC with compensatory UTE/T2W imaging, striking contrast enhancement could
be readily detected in areas containing macrophage-rich plaques at 24 h (Fig 5).[26] In UTE
imaging, the increase in positive signal correlated with DMNC-laden macrophage density in
plaque areas and allowed for the highly sensitive and specific detection of macrophages. From
T2W imaging, negative contrast could be detected in the wall of the aorta, which was not pres-
ent at baseline. T2W imaging could provide better resolution of in vivoMR images of the aorta
than seen with UTE imaging, although subtle spots of negative contrast could not be exclusive-
ly attributed to DMNC deposition, due to signal voids caused by respiratory motion artifacts or
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the absence of tissue in the same area. For the better understanding of imaging results, sub-
tracted images for each UTE and T2W are presented in S2 Fig These positive and negative sig-
nals on the in vivoMR images corresponded to the deposition of DMNC in macrophage-rich
atherosclerotic plaques, as seen on ex vivoMR imaging results and histological analysis (Fig 6).
Conclusion
In this study, UTE/T2W imaging was combined with macrophage-targetable DMNC to gener-
ate compensatory positive and negative contrast images of atherosclerotic plaques. Using this
compensatory MR imaging technique, the intraluminal kinetics of DMNC was investigated
and areas containing macrophage-rich plaques could be highlighted. UTE imaging with posi-
tive contrast effectively supplemented the typical weaknesses of T2W imaging: contrast void
and signal saturation. From this result, DMNC enabled specifically targeted atherosclerosis
MR imaging and the presented compensatory imaging technique should provide non-invasive
evaluation of inflammatory vascular wall, and useful to monitor therapeutic interventions
of atherosclerosis.
Supporting Information
S1 Fig. Characterization of DMNC. (a) TEM image of DMNC. (b) Size and surface charge
variation of DMNC over 15 days. (c) R2 graph of DMNC from solution MR imaging at various
Fe concentrations.
(TIF)
S2 Fig. Subtracted in vivo MR imaging of WHHL rabbit after DMNC injection. Subtracted
images of thoracic aorta using (a) T2W imaging (Sub = Pre—Post) and (b) UTE imaging
(Sub = Post—Pre).
(TIF)
S1 Supporting Text. Supporting file in text.
(DOCX)
S1 Table. Signal intensities and relative signal intensities of DMNC solutions.
(TIF)
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